Cancer

HUTCHMED Announces Continued Inclusion of ORPATHYS® (savolitinib) in the National Reimbursement Drug List in China at Current Terms

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 28, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13)...

Surgical Robots Market to Grow by USD 14.02 Billion (2024-2028), Rising Adoption for Convenience Drives Growth, Report on AI-Driven Market Transformation – Technavio

error: Content is protected !!